Latest issue

January - April 2020 Boehringer Tngelheim, Enleofen Tnk $1B-Per-Product Anti-TL-11 Partnership Focused on NASH, Lung Disorders Boehringer Ingelheim announced...

September - December 2019 In Stunning Twist, FDA Approves Sarepta’s Duchenne Drug It Rejected The Food and Drug Administration approved Sarepta’s Duchenne mu...

May - August 2019 Measles Outbreak Now at 880 Cases, With Fastest Growth Still in New York There have now been 880 measles cases reported in this year’s outb...

Oct - Dec, 2016 Trump Proposes to Lower Drug Prices by Basing Them on Other Countries’ Costs In a speech at the U.S. Department of Health and Human Services ...

May-July, 2018 Diabetes Patients at Risk from Rising Insulin Prices A Yale study found that one in four patients admitted to cutting back on insulin use beca...

Dec, 2017 - April, 2018 Humira’s Best-Selling Drug Formula: Start at a High Price. Go Higher The price of Humira, an anti-inflammatory drug dispensed in an i...

September-November, 2017 Former CDC Chief Launches $225 Million Global Health Initiative Tom Frieden, former director of the Centers for Disease Control and ...

June - July, 2017 With Obamacare, More Breast Cancers Diagnosed at Earlier Stages More breast cancers have been found at earlier — and potentially more treat...

February-April, 2017 FDA Approves Regeneron, Sanofi $37,000 Per Year Eczema Drug The U.S. Food and Drug Administration approved Regeneron Pharmaceuticals Inc...

Sep-Dec, 2016 Doctors Spending in Excess of $32,000 on Health IT Doctors are spending more than $32,000 per year on health information technology (IT), accor...